Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.
Current disciplines include:
A podcast of the specialty series is available to download, providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions You can also listen online – search by your area of interest to filter interviews relevant to you.
Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.
Respiratory. In this interview we discuss a recent study, the IMPACT study, which has looked at exacerbations and all-cause mortality differences in a head to head study comparing a number of inhaler strategies. This is an important study which answers some really important clinical questions.
Psychiatry. People with schizophrenia are well known to be at risk of metabolic syndrome, and some of the medications we use increase that risk quite markedly. Recently an audit was conducted to identify patients with schizophrenia across Australia who have metabolic problems, and look at the various interventions that might be effective for them. In this interview we discuss the key findings.
Psychiatry. When treating depression what do patients want, ‘to ameliorate depressive symptoms’ or ‘to return to normal functioning’? In this interview we discuss individualised management that takes patient’s symptoms priorities and treatment expectations into account.
Epilepsy: In Australia, up to 2,000 women on anti-epileptic drugs become pregnant each year but there is concern, particularly in the neurological community, about the possible risks for these drugs and their teratogenicity. Neurologists have to balance the risks of both seizures and the risks of the medications and striking a balance is difficult – listen to learn more.
Epilepsy: Epilepsy is one of the most common neurological illnesses, affecting three to four per cent of people in the developing world, and while we have a wealth of treatment options, many of these are now very old. In this interview we focus on the treatment options available to us as physicians and look at what this means to the patient and what factors we ought to consider.
Endocrinology. In this interview we discuss cases which are less than typical, the sort of patients that we are often referred by general practitioners. We apply the evidence to; Migraine, VTE, BRCA 1 and 2, and premature ovarian insufficiency, all situations that we’re more likely to see in secondary care. 30-minute listen
Endocrinology: There’s been a spotlight on hormone therapy and breast cancer recently. Research is showing that women do not understand the long-term health consequences of menopause. So, what do we need to consider and how should we explain the multidimensional effects of menopause and of hormone therapy to our patients? 20-minute listen
Ophthalmology. Many patients either present with bilateral disease or progress when having the macula affected in one eye, to both eyes within a few years. The key clinical question is; how clinical practice should be adapted when moving from unilateral to bilateral anti-VEGF therapy. In this interview we discuss pragmatic considerations to reduce the burden of bilateral anti-VEGF injections while mitigating any additional risks.
Ophthalmology. Since the introduction of anti-VEGF therapies, real world outcomes have generally not been as good as those observed in the trials. The question is whether this is due to the use of reactive approaches to therapy or whether proactive approaches to therapy might actually be better, and is there any evidence for ophthalmologists moving to proactive therapy. We discuss some of these questions in this interview.
Respiratory. A lot has changed in the world of pulmonary fibrosis in the last few years, in terms of what treatments are available and what this means for our patients. We now have options to slow disease progression down and to prolong life, listen to learn more.
Tap the share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!